Rowlinson Scott W 4
4 · Aeglea BioTherapeutics, Inc. · Filed Aug 24, 2017
Insider Transaction Report
Form 4
Rowlinson Scott W
VP, Research
Transactions
- Award
Employee Stock Option (right to buy)
2017-08-22+25,000→ 25,000 totalExercise: $3.10Exp: 2027-08-21→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date.